Advances in Material-Based Strategies for Diabetic Bone Regeneration

Stem Cells Transl Med. 2024 Mar 15;13(3):243-254. doi: 10.1093/stcltm/szad092.

Abstract

Increased bone fragility and poor bone healing are common and serious complications of diabetes, especially in elderly patients. Long-term hyperglycemia often leads to serious infection and nonunion. Diabetes brings changes to bone microenvironment, including imbalanced immunity, disorder of macrophage polarization, deterioration of microvascular system, excessive advanced glycation end products, reactive oxygen species (ROS), local high levels of glucose, and great tendency to infection. The main traditional managements of diabetic bone involve oral medication and systematic drug administration, which exhibit limited therapeutic efficacy and accompanied side effects. Materials-based strategies have recently been potential alternatives for the treatment of diabetic bone diseases. In this review, we highlight the main material-based strategies for diabetic bone repair deficiency, including regulation of macrophages, elimination of excessive ROS, and resistance to bacterial infection. We also describe the future therapeutic designing approaches for smart biomaterials for diabetic bone regeneration, which would provide new ideas to protect bone health in patients with diabetes.

Keywords: biomaterials; bone tissue engineering; diabetes.

Publication types

  • Review

MeSH terms

  • Aged
  • Bone Regeneration
  • Diabetes Mellitus*
  • Glycation End Products, Advanced / therapeutic use
  • Humans
  • Hyperglycemia* / drug therapy
  • Reactive Oxygen Species

Substances

  • Reactive Oxygen Species
  • Glycation End Products, Advanced